In the research of Vella et al. (2001), they found that the activation of the insulin-like growth factor (IGF) system in cancer has emerged as a key factor for tumor progression and resistance to apoptosis, and experiments validated that IGF system members were found to be locally produced in thyroid cancer. This evidence concerns the gene IGF1 and thyroid cancer.